Invitrogen, ABI, Agencourt, Global Genographic, Beckman Coulter, Artel Tech, Daiichi Pure Chemicals, Toshiba, Toshiba Hokuto Electronics | GenomeWeb

Invitrogen Becomes First Shop to Sign On to Crucell's PER.C6 Vendor Network

Dutch biotech Crucell and DSM Biologics said this week that Invitrogen will become the first company to enter the partnership's licensing business, Vendor Network, for monoclonal antibodies and recombinant proteins.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.